ClinicalTrials.gov
ClinicalTrials.gov Menu

Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00777972
Recruitment Status : Completed
First Posted : October 23, 2008
Last Update Posted : October 23, 2008
Sponsor:
Information provided by:
Ranbaxy Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2003
  Actual Study Completion Date : April 2003